anti glp 1 drugs America's Poison Centers The GLP-1 Agonists and Obesity:
Description
Obesity Reviews , 26(8), e13929
Hormone support becomes metabolic balance
For tirzepatide, the prescribing information does not specify a preconception interval but advises discontinuation when pregnancy is recognized
However, further research is needed to determine who may be at greatest risk and whether certain dosing strategies could mitigate these complications
The sudden onset of these gallbladder issues in patients taking GLP-1 drugs has prompted many to question the completeness of the manufacturers' safety information
